Paper7204965
Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum.
Kull FC and 1 other. J Immunol, 1981. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum. Papers, record 7204965. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7204965
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood | Major topic |
| Cytotoxins | Major topic |
| Necrosis | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Cell Adhesion | |
| Cell Survival | |
| Chemical Fractionation | |
| Chemical Phenomena | |
| Chemistry, Physical | |
| Chromatography, Gel | |
| Chromatography, Ion Exchange | |
| Fibroblasts | |
| Male | |
| Mice | |
| Molecular Weight |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24563506 | True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. | J Immunol | 2014 | https://conductscience.org/library/papers/24563506 | PubMed |
| 7764664 | The determination of cellular viability of hybridoma cells in microtitre plates: a colorimetric assay based on neutral red. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7764664 | PubMed |
| 6750231 | Possible role of endotoxin in mediating host resistance. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/6750231 | PubMed |
| 6604918 | Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6604918 | PubMed |
| 6595667 | Necrosin: purification and properties of a cytotoxin derived from a murine macrophage-like cell line. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6595667 | PubMed |
| 6591854 | Estimation of cell number by neutral red content. Applications for proliferative and survival assays. | Appl Biochem Biotechnol | 1983 | https://conductscience.org/library/papers/6591854 | PubMed |
| 6490095 | Anti-tumour cytotoxin from macrophages: no correlation between cytotoxin adsorption by tumour cell lines and their cytotoxin susceptibility. | Immunology | 1984 | https://conductscience.org/library/papers/6490095 | PubMed |
| 6467675 | Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6467675 | PubMed |
| 6421983 | Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin. | J Exp Med | 1984 | https://conductscience.org/library/papers/6421983 | PubMed |
| 6360852 | Production of lymphocyte activating factor in vivo. | Immunology | 1983 | https://conductscience.org/library/papers/6360852 | PubMed |
| 6196106 | Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6196106 | PubMed |
| 6193516 | Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6193516 | PubMed |
| 6186366 | Endotoxin-induced release of tumour necrosis factor and interferon in vivo is inhibited by prior adrenoceptor blockade. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6186366 | PubMed |
| 3930066 | Cytotoxic factor production by Kupffer cells elicited with Lactobacillus casei and Corynebacterium parvum. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/3930066 | PubMed |
| 3898078 | Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3898078 | PubMed |
| 3874163 | Influence of acute-phase proteins on the activity of natural killer cells. | Inflammation | 1985 | https://conductscience.org/library/papers/3874163 | PubMed |
| 3863119 | Purification and characterization of a human tumor necrosis factor from the LuKII cell line. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3863119 | PubMed |
| 3829051 | Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3829051 | PubMed |
| 3586573 | Tumor necrosis factor: recent advances. | Klin Wochenschr | 1987 | https://conductscience.org/library/papers/3586573 | PubMed |
| 3520561 | Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3520561 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7204965
GET https://conductscience.org/api/papers/v1/7204965/cited_by?page=2